New hope for kids battling leukemia that Won't stay away
NCT ID NCT05192889
Summary
This study is testing a new combination of two drugs, venetoclax and navitoclax, for children and young adults whose acute lymphoblastic leukemia has come back or hasn't responded to previous treatments. The main goals are to see if this combination can effectively clear the cancer from the bone marrow and to find the safest and most effective dose for future use. The trial is also testing different follow-up treatments based on specific features of a patient's cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
-
St. Jude Children's Research Hospital
Memphis, Tennessee, 38105, United States
Conditions
Explore the condition pages connected to this study.